Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Molecular and Cellular Biology|October 13, 2025
The Role of Tumor-Intrinsic HuR in Modeling the Pancreatic Tumor Microenvironment: Molecular Mechanisms and Therapeutic OpportunitiesKatherine R Pelz, Kyle P Gribbin, Tess Sevetson, et al.
Journal of Cachexia, Sarcopenia and Muscle|January 23, 2019
MyD88 signalling is critical in the development of pancreatic cancer cachexiaXinxia Zhu, Kevin G Burfeind, Katherine A Michaelis, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2025
MicroCT enables simultaneous longitudinal tracking of murine pancreatic cancer progression and cachexiaKatherine R Pelz, Philip Jimenez, Colin J Daniel, et al.
Cancer Research Communications|November 24, 2025
MicroCT Enables Simultaneous Longitudinal Tracking of Murine Pancreatic Cancer Progression and CachexiaKatherine R Pelz, Philip Jimenez, Colin J Daniel, et al.
Nature Communications|April 7, 2021
Lipocalin 2 mediates appetite suppression during pancreatic cancer cachexiaBrennan Olson, Xinxia Zhu, Mason A Norgard, et al.
Cancer Research|November 4, 2018
Activation of PP2A and Inhibition of mTOR Synergistically Reduce MYC Signaling and Decrease Tumor Growth in Pancreatic Ductal AdenocarcinomaBrittany L Allen-Petersen, Tyler Risom, Zipei Feng, et al.
Nature Communications|October 17, 2019
The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancerKatherine A Michaelis, Mason A Norgard, Xinxia Zhu, et al.
Nature Communications|November 16, 2019
Publisher Correction: The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancerKatherine A Michaelis, Mason A Norgard, Xinxia Zhu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 12, 2025
Randomized Phase II Study of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab as First-Line Treatment in Advanced Pancreatic Cancer: Survival and CachexiaInna M Chen, Julia S Johansen, Susann Theile, et al.
Cancer Research|September 18, 2025
The Prolyl Isomerase PIN1 Affects Fibroblast Differentiation States and Cross-talk in Pancreatic CancerChloe L Bowman, Colin J Daniel, Eric J Carlson, et al.
Pageof 1